
Hanna Gaggin
@hannagaggin
cardiologist, scientist, mom of 3 @MassGeneral @HarvardMed via @uva @EVMSedu @uvahealthnews @HarvardChanSPH @PittCardiology Personal views not of my employer
ID: 1028453803
https://www.massgeneral.org/doctors/doctor.aspx?id=19072# 22-12-2012 12:50:01
2,2K Tweet
1,1K Takipçi
1,1K Takip Edilen




Proud to be on pubmed with this stellar team ! Cian McCarthy @RezaMohebiMD Hanna Gaggin Dr Roxana Mehran George Dangas, MD, MACC, MSCAI and @JJheart_doc ahajournals.org/doi/10.1161/JA…

Comprehensive review of lipoprotein(a) and cardiovascular disease jamanetwork.com/journals/jamac… JAMA Cardiology


DELIVER Study Design by scottdavidsolomon 🎯 Comparison of HFpEF Trials 💊 Medication use in HFpEF Trials #HeartFailure2022 European Society of Cardiology


HF superstar Muthu Vaduganathan presented a very interesting analysis of combination therapy with MRA+ARNI+SGLT2i in HFmrEF and HFpEF at #HeartFailure2022 🥊Substantial benefits up to EF 60-65% Muthu Vaduganathan’s second SimPub in Circulation this meeting!!


Just out in @jaccjournals jacc.org/doi/10.1016/j.… our COVID proteomics study led by Jason Roh identifying actionable pathways in patients with cardiac involvement. Appreciate editorial by Drs. George Vasquez-Rios, MD MSCR, FASN and Girish Nadkarni jacc.org/doi/10.1016/j.…


Great variability of parental benefits and policies among cardiovascular training programs can have negative impact on work-life balance. JACC Journals Incredible effort led by Estefania Oliveros MD🫀 Dr Roxana Mehran Ki Park Doreen DeFaria Yeh, MD Nosheen Reza, MD, MS @ErikaJSqueri jacc.org/doi/10.1016/j.…


We could not be more excited to welcome Dr Roxana Mehran for the 11th Annual Peter M. Yurchak Lecture. A true #WIC legend and inspiration. It’s going to be a great day! Mass General Heart #womensCVD #inclusionincardiology #CardioTwitter

Dr Roxana Mehran at Peter Yurchak Mass General Heart lecture - underrepresentation of women in trials is a barrier to understanding heterogeneous treatment effects and developing sex-specific treatment strategies Harvard Medical School MassGeneral News



Classifying heart failure based on ejection fraction: imperfect but enduring Steve Greene Shahzeb Khan doi.org/10.1002/ejhf.2…




Hot off the press! Our review article in JACC Journals on the applications of ML and devices in HF. doi.org/10.1016/j.jchf… Thanks to my mentors Dr. Al’Aref and Marat Fudim, MD MHS Steve Greene Mark Rabbat MD for the valuable guidance! UAMS Internal Medicine Residency UAMS Cardiology Fellowship


What are the implications of encountering a reduced EF (<40%) on initial presentation in patients with Cardiac Amyloidosis? What factors are associated with this? Outstanding new work from Trejeeve (Tre) Martyn W. H. Wilson Tang, MD in JACC Journals #JACCHF 📎 jacc.org/doi/10.1016/j.…


Effects of ARNI on Major Coronary Events in 👥 With Acute Myocardial Infarction #PARADISE-MI Trial 👥 STEMI 76%, non–STEMI 24% 👥89% undergone coronary reperfusion ⏰22m 👉SV vs ramipril, ⤵️16% risk of coronary outcomes Asociación CI y Cuidados Agudos Cardiovasculares


Going to AHAMeetings since 2007 with my best friend Hanna Gaggin! #AHA22 was a wonderful meeting🫀Until next year!
